Search for: "Deas v. Deas" Results 61 - 80 of 790
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Dec 2023, 12:30 pm by John Ross
But officials broke "[v]irtually every promise" they made. [read post]
7 Nov 2023, 6:05 pm
Schedules III, IV, and V will typically carry lighter charges depending on volume and intent. [read post]
8 Oct 2023, 6:46 pm by Kurt R. Karst
  Instead, DEA states: This extension authorizes all DEA-registered practitioners to prescribe schedule II–V controlled medications via telemedicine through December 31, 2024, whether or not the patient and practitioner established a telemedicine relationship on or before November 11, 2023. [read post]
26 Sep 2023, 1:43 am
Desktop pharmacy audits are done in-house on claims that have been adjudicated, also known as Documentation and Verification Audits (D&V). [read post]
5 Sep 2023, 8:42 pm by Kurt R. Karst
  (DEA initially placed Epidiolex in schedule V, then later decontrolled it). [read post]
9 Aug 2023, 6:00 pm by Kurt R. Karst
  Any authorized refills included on schedule III-V prescriptions transfer with the original prescription. [read post]
7 Aug 2023, 8:40 am by Delia A. Deschaine
” Helpfully, DEA is asking those who plan to attend the listening sessions to consider the following questions ahead of time: If telemedicine prescribing of schedule III-V medications were permitted in the absence of an in-person medical evaluation, what framework, including safeguards and data, with respect to telemedicine prescribing of schedule III-V medications do you recommend to help the agency ensure patient safety and prevent diversion of controlled… [read post]
31 Jul 2023, 3:12 am by Kurt R. Karst
  Letter from Congress of the United States, to Robert Patterson, Acting Administrator, DEA (Dec. 21, 2017). [read post]
11 Jul 2023, 6:39 am by Joseph L. Hyde
  Stillwell’s post-arrest confession to DEA agents was plainly testimonial. [read post]
5 Jul 2023, 8:31 am by Kevin S. Little
Some of the most significant updates include the following: Registration Requirements Generally, every practitioner who dispenses, which includes by definition administering and prescribing, controlled substances in schedules II through V, must be registered with DEA. [read post]